Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
Coombes, RC, Prof, Kilburn, LS, MSc, Snowdon, CF, MSc, Paridaens, R, Prof, Coleman, RE, Prof, Jones, SE, MD, Jassem, J, Prof, Van de Velde, CJH, Prof, Delozier, T, MD, Alvarez, I, MD, Del Mastro, L, MD, Ortmann, O, Prof, Diedrich, K, Prof, Coates, AS, Prof, Bajetta, E, Prof, Holmberg, SB, MD, Dodwell, D, MD, Mickiewicz, E, MD, Andersen, J, DMSc, Lønning, PE, Prof, Cocconi, G, Prof, Forbes, J, Prof, Castiglione, M, Prof, Stuart, N, MD, Stewart, A, MD, Fallowfield, LJ, Prof, Bertelli, G, MD, Hall, E, PhD, Bogle, RG, MD, Carpentieri, M, PhD, Colajori, E, MD, Subar, M, MD, Ireland, E, MSc, Bliss, JM, Prof
Published in The Lancet (British edition) (17.02.2007)
Published in The Lancet (British edition) (17.02.2007)
Get full text
Journal Article
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
Rabaglio, M., Sun, Z., Price, K.N., Castiglione-Gertsch, M., Hawle, H., Thürlimann, B., Mouridsen, H., Campone, M., Forbes, J.F., Paridaens, R.J., Colleoni, M., Pienkowski, T., Nogaret, J.-M., Láng, I., Smith, I., Gelber, R.D., Goldhirsch, A., Coates, A.S.
Published in Annals of oncology (01.09.2009)
Published in Annals of oncology (01.09.2009)
Get full text
Journal Article
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Viale, G., Regan, M.M., Dell'Orto, P., Mastropasqua, M.G., Maiorano, E., Rasmussen, B.B., MacGrogan, G., Forbes, J.F., Paridaens, R.J., Colleoni, M., Láng, I., Thürlimann, B., Mouridsen, H., Mauriac, L., Gelber, R.D., Price, K.N., Goldhirsch, A., Gusterson, B.A., Coates, A.S.
Published in Annals of oncology (01.10.2011)
Published in Annals of oncology (01.10.2011)
Get full text
Journal Article
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases
BEUSELINCK, B, WOLTER, P, POPPEL, H. Van, LERUT, E, DEBRUYNE, P, PARIDAENS, R, SCHÖFFSKI, P, KARADIMOU, A, ELAIDI, R, DUMEZ, H, ROGIERS, A, CANN, T. Van, WILLEMS, L, BODY, J.-J, BERKERS, J
Published in British journal of cancer (06.11.2012)
Published in British journal of cancer (06.11.2012)
Get full text
Journal Article
A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative
Brouckaert, O., Paridaens, R., Floris, G., Rakha, E., Osborne, K., Neven, P.
Published in Annals of oncology (01.01.2013)
Published in Annals of oncology (01.01.2013)
Get full text
Journal Article
Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers
Brouckaert, O., Laenen, A., Vanderhaegen, J., Wildiers, H., Leunen, K., Amant, F., Berteloot, P., Smeets, A., Paridaens, R., Christiaens, M.R., Floris, G., Moerman, P., Van Limbergen, E., Peeters, S., Weltens, C., Vergote, I., Neven, P.
Published in Annals of oncology (01.10.2012)
Published in Annals of oncology (01.10.2012)
Get full text
Journal Article
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib
BEUSELINCK, B, KARADIMOU, A, VERKARRE, V, LERUT, E, DE LA TAILLE, A, TOURANI, J.-M, BIGOT, P, LINASSIER, C, NEGRIER, S, BERGER, J, PATARD, J.-J, ZUCMAN-ROSSI, J, LAMBRECHTS, D, OUDARD, S, CLAES, B, WOLTER, P, COUCHY, G, BERKERS, J, PARIDAENS, R, SCHÖFFSKI, P, MEJEAN, A
Published in British journal of cancer (05.03.2013)
Published in British journal of cancer (05.03.2013)
Get full text
Journal Article
Conventional rotational molding process and aerodynamic characteristics of an axial-flow hollow blades rotor
Lucas, A., Danlos, A., Shirinbayan, M., Motaharinejad, V., Paridaens, R., Benfriha, K., Bakir, F., Tcharkhtchi, A.
Published in International journal of advanced manufacturing technology (01.09.2019)
Published in International journal of advanced manufacturing technology (01.09.2019)
Get full text
Journal Article
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI
Lintermans, A., Van Asten, K., Wildiers, H., Laenen, A., Paridaens, R., Weltens, C., Verhaeghe, J., Vanderschueren, D., Smeets, A., Van Limbergen, E., Leunen, K., Christiaens, M. R., Neven, P.
Published in Breast cancer research and treatment (01.07.2014)
Published in Breast cancer research and treatment (01.07.2014)
Get full text
Journal Article
Body mass index, age at breast cancer diagnosis, and breast cancer subtype: a cross-sectional study
Brouckaert, O., Van Asten, K., Laenen, A., Soubry, A., Smeets, A., Nevelstreen, I., Vergote, I., Wildiers, H., Paridaens, R., Van Limbergen, E., Weltens, C., Moerman, P., Floris, G., Neven, P.
Published in Breast cancer research and treatment (01.02.2018)
Published in Breast cancer research and treatment (01.02.2018)
Get full text
Journal Article
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-up
Haest, K., Kumar, A., Van Calster, B., Leunen, K., Smeets, A., Amant, F., Berteloot, P., Wildiers, H., Paridaens, R., Van Limbergen, E., Weltens, C., Janssen, H., Peeters, S., Menten, J., Vergote, I., Morlion, B., Verhaeghe, J., Christiaens, M.R., Neven, P.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Perey, L., Paridaens, R., Hawle, H., Zaman, K., Nolé, F., Wildiers, H., Fiche, M., Dietrich, D., Clément, P., Köberle, D., Goldhirsch, A., Thürlimann, B.
Published in Annals of oncology (01.01.2007)
Published in Annals of oncology (01.01.2007)
Get full text
Journal Article
Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer
Paridaens, R., Dirix, L., Lohrisch, C., Beex, L., Nooij, M., Cameron, D., Biganzoli, L., Cufer, T., Duchateau, L., Hamilton, A., Lobelle, J. P., Piccart, M.
Published in Annals of oncology (01.09.2003)
Published in Annals of oncology (01.09.2003)
Get full text
Journal Article
Prediction of lymph node involvement in breast cancer from primary tumor tissue using gene expression profiling and miRNAs
Smeets, A., Daemen, A., Vanden Bempt, I., Gevaert, O., Claes, B., Wildiers, H., Drijkoningen, R., Van Hummelen, P., Lambrechts, D., De Moor, B., Neven, P., Sotiriou, C., Vandorpe, T., Paridaens, R., Christiaens, M. R.
Published in Breast cancer research and treatment (01.10.2011)
Published in Breast cancer research and treatment (01.10.2011)
Get full text
Journal Article
Paclitaxel Versus Doxorubicin as First-Line Single-Agent Chemotherapy for Metastatic Breast Cancer: A European Organization for Research and Treatment of Cancer Randomized Study With Cross-Over
PARIDAENS, R, BIGANZOLI, L, AWADA, A, WILDIERS, J, PICCART, M, BRUNING, P, KLIJN, J. G. M, GAMUCCI, T, HOUSTON, S, COLEMAN, R, SCHACHTER, J, VAN VRECKEM, A, SYLVESTER, R
Published in Journal of clinical oncology (01.02.2000)
Published in Journal of clinical oncology (01.02.2000)
Get full text
Journal Article
Association between tumour characteristics and HER-2/neu by immunohistochemistry in 1362 women with primary operable breast cancer
Huang, H J, Neven, P, Drijkoningen, M, Paridaens, R, Wildiers, H, Van Limbergen, E, Berteloot, P, Amant, F, Vergote, I, Christiaens, M R
Published in Journal of clinical pathology (01.06.2005)
Published in Journal of clinical pathology (01.06.2005)
Get full text
Journal Article
Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel
Vulsteke, C., Pfeil, A. M., Schwenkglenks, M., Pettengell, R., Szucs, T. D., Lambrechts, D., Peeters, M., van Dam, P., Dieudonné, A. S., Hatse, S., Neven, P., Paridaens, R., Wildiers, H.
Published in Breast cancer research and treatment (01.10.2014)
Published in Breast cancer research and treatment (01.10.2014)
Get full text
Journal Article
Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data
Lintermans, A., Laenen, A., Van Calster, B., Van Hoydonck, M., Pans, S., Verhaeghe, J., Westhovens, R., Henry, N.L., Wildiers, H., Paridaens, R., Dieudonné, A.S., Leunen, K., Morales, L., Verschueren, K., Timmerman, D., De Smet, L., Vergote, I., Christiaens, M.R., Neven, P.
Published in Annals of oncology (01.02.2013)
Published in Annals of oncology (01.02.2013)
Get full text
Journal Article
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
Mauriac, L, Keshaviah, A, Debled, M, Mouridsen, H, Forbes, JF, Thürlimann, B, Paridaens, R, Monnier, A, Láng, I, Wardley, A, Nogaret, J-M, Gelber, RD, Castiglione-Gertsch, M, Price, KN, Coates, AS, Smith, I, Viale, G, Rabaglio, M, Zabaznyi, N, Goldhirsch, A
Published in Annals of oncology (01.05.2007)
Published in Annals of oncology (01.05.2007)
Get full text
Journal Article